Sodium beta-hydroxybutyrate

N/A

Report date: 2023/04/05 20:00:19
NME

Base Information

Drug NameSodium beta-hydroxybutyrate
Drug Alias NameKTX-0101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals scavengers
TargetsFree radicals
Therapy Area/IndicationsHypoglycemiaDiabetes Mellitus, Type 1Brain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBtg Plc
China Registration ClassN/A

Develop Information

Active CompaniesYale University
Active IndicationsHypoglycemiaDiabetes Mellitus, Type 1
Inactive IndicationsBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A